{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:59:26Z","timestamp":1775620766632,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2706100"],"award-info":[{"award-number":["2023YFC2706100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970111"],"award-info":[{"award-number":["81970111"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jtha.2024.12.028","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T00:53:46Z","timestamp":1736038426000},"page":"1442-1451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic potential of roxadustat in immune thrombocytopenia: a Mendelian randomization analysis"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3737-0876","authenticated-orcid":false,"given":"Jingyao","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juntao","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4030-209X","authenticated-orcid":false,"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.12.028_bib1","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.12.028_bib2","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.12.028_bib3","first-page":"789","article-title":"Primary immune thrombocytopenia: novel insights into pathophysiology and disease management","volume":"10","author":"Singh","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2024.12.028_bib4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/17474086.2021.1995347","article-title":"Immune thrombocytopenia","volume":"14","author":"Bussel","year":"2021","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jtha.2024.12.028_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/17512433.2021.1903315","article-title":"Update on diagnosis and treatment of immune thrombocytopenia","volume":"14","author":"Sandal","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.jtha.2024.12.028_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102345","article-title":"Immune attack on megakaryocytes in immune thrombocytopenia","volume":"8","author":"Petito","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.12.028_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1182\/blood-2013-07-516336","article-title":"Pharmacologic increase in HIF1alpha enhances hematopoietic stem and progenitor homing and engraftment","volume":"123","author":"Speth","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.028_bib8","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","article-title":"Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma","volume":"113","author":"DiPersio","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.028_bib9","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1055\/s-0039-1694030","article-title":"Downregulation of hypoxia-inducible factor-1alpha contributes to impaired megakaryopoiesis in immune thrombocytopenia","volume":"117","author":"Qi","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.12.028_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633586","article-title":"Oxygen-mediated suppression of CD8+ T cell proliferation by macrophages: role of pharmacological inhibitors of HIF degradation","volume":"12","author":"Gojkovic","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.12.028_bib11","first-page":"1525","article-title":"Cyclic thrombocytopenia related to erythropoietin-dependent anti-platelet anti-GPIV\/IIIb antibody in hemodialysis","volume":"35","author":"Florens","year":"2022","journal-title":"J\u00a0Nephrol"},{"key":"10.1016\/j.jtha.2024.12.028_bib12","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3324\/haematol.2022.282209","article-title":"Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia","volume":"108","author":"Wang","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.12.028_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/bjh.18377","article-title":"Upregulation of HIF-1alpha contributes to complement activation in transplantation-associated thrombotic microangiopathy","volume":"199","author":"Qi","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.12.028_bib14","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41467-019-09432-2","article-title":"Mendelian randomization analysis using mixture models for robust and efficient estimation of causal effects","volume":"10","author":"Qi","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2024.12.028_bib15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtha.2024.12.028_bib16","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","article-title":"Mendelian randomization for cardiovascular diseases: principles and applications","volume":"44","author":"Larsson","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2024.12.028_bib17","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtha.2024.12.028_bib18","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A\u00a0cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.jtha.2024.12.028_bib19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1186\/s12967-024-05680-z","article-title":"Mitochondrial dysfunction gene expression, DNA methylation, and inflammatory cytokines interaction activate Alzheimer's disease: a multi-omics Mendelian randomization study","volume":"22","author":"Zhang","year":"2024","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jtha.2024.12.028_bib46","unstructured":"Team R.C. R: A language and environment for statistical computing. R\u00a0Foundation for Statistical Computing. https:\/\/www.R-project.org\/; 2013. [accessed January 29, 2025]."},{"key":"10.1016\/j.jtha.2024.12.028_bib47","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.jtha.2024.12.028_bib48","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/gepi.21765","article-title":"Statistical testing of shared genetic control for potentially related traits","volume":"37","author":"Wallace","year":"2013","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.jtha.2024.12.028_bib49","series-title":"Meta-analysis with R","author":"Schwarzer","year":"2015"},{"key":"10.1016\/j.jtha.2024.12.028_bib20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1901713","article-title":"Roxadustat treatment for anemia in patients undergoing long-term dialysis","volume":"381","author":"Chen","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.12.028_bib21","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/ATVBAHA.121.316495","article-title":"Roxadustat does not affect platelet production, activation, and thrombosis formation","volume":"41","author":"Zhao","year":"2021","journal-title":"Arterioscler, Thromb, Vasc Biol"},{"key":"10.1016\/j.jtha.2024.12.028_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12935-019-0779-0","article-title":"Megakaryocytic dysfunction in immune thrombocytopenia is linked to autophagy","volume":"19","author":"Sun","year":"2019","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jtha.2024.12.028_bib23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s12015-019-09905-3","article-title":"Biological characteristics and regulation of early megakaryocytopoiesis","volume":"15","author":"Yang","year":"2019","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.jtha.2024.12.028_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2024.102376","article-title":"Activation of BMP4\/SMAD pathway by HIF-1alpha in hypoxic environment promotes osteogenic differentiation of BMSCs and leads to ectopic bone formation","volume":"88","author":"Chen","year":"2024","journal-title":"Tissue Cell"},{"key":"10.1016\/j.jtha.2024.12.028_bib25","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3389\/fimmu.2018.00880","article-title":"Emerging concepts in immune thrombocytopenia","volume":"9","author":"Swinkels","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.12.028_bib26","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.3390\/ijms25042163","article-title":"Current understanding of immune thrombocytopenia: a review of pathogenesis and treatment options","volume":"25","author":"Mititelu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2024.12.028_bib27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20131916","article-title":"PD-L1 is a novel direct target of HIF-1\u03b1, and its blockade under hypoxia enhanced MDSC-mediated T cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jtha.2024.12.028_bib28","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1093\/hmg\/ddw197","article-title":"Challenges and novel approaches for investigating molecular mediation","volume":"25","author":"Richmond","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jtha.2024.12.028_bib29","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJMe2110953","article-title":"Immune thrombocytopenia treatment","volume":"385","author":"Bolton-Maggs","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.12.028_bib30","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/bloodadvances.2023012541","article-title":"2022 Review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia","volume":"8","author":"Neunert","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.12.028_bib31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/medicina56120667","article-title":"Immune thrombocytopenia (ITP): current limitations in patient management","volume":"56","author":"Terrell","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jtha.2024.12.028_bib32","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s40265-021-01553-7","article-title":"Thrombopoietin receptor agonists (TPO-RAs): drug class considerations for pharmacists","volume":"81","author":"Gilreath","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.jtha.2024.12.028_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.thromres.2022.09.021","article-title":"Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: a Canadian retrospective cohort study","volume":"220","author":"Podstawka","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.12.028_bib34","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood.2021010968","article-title":"How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment","volume":"137","author":"Ghanima","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.028_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100774","article-title":"Hemostatic changes by thrombopoietin-receptor agonists in immune thrombocytopenia patients","volume":"47","author":"van Dijk","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2024.12.028_bib36","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/09537104.2020.1809648","article-title":"Myelofibrosis in ITP and with TPO-RA - time to rethink?","volume":"32","author":"Thachil","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2024.12.028_bib37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/FTD.0000000000000522","article-title":"Eltrombopag-induced acute liver failure in a pediatric patient: a pharmacokinetic and pharmacogenetic analysis","volume":"40","author":"Marano","year":"2018","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jtha.2024.12.028_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1215216","article-title":"Rituximab resistance in ITP and beyond","volume":"14","author":"Xiao","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.12.028_bib39","doi-asserted-by":"crossref","first-page":"e593","DOI":"10.1016\/S2352-3026(21)00167-8","article-title":"Southern Network on Adverse Reactions. Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions","volume":"8","author":"Bennett","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtha.2024.12.028_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.572863","article-title":"Rituximab hypersensitivity: from clinical presentation to management","volume":"11","author":"Fouda","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtha.2024.12.028_bib41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/1744666X.2019.1562905","article-title":"Infusion-related reactions to rituximab: frequency, mechanisms and predictors","volume":"15","author":"Paul","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jtha.2024.12.028_bib42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s10194-023-01612-2","article-title":"Exploring the bidirectional relationship between pain and mental disorders: a comprehensive Mendelian randomization study","volume":"24","author":"Yao","year":"2023","journal-title":"J\u00a0Headache Pain"},{"key":"10.1016\/j.jtha.2024.12.028_bib43","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1055-9965.EPI-17-1177","article-title":"Causal inference in cancer epidemiology: what is the role of mendelian randomization?","volume":"27","author":"Yarmolinsky","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jtha.2024.12.028_bib44","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1182\/blood-2023-184311","article-title":"ATRA can correct impaired proplatelet formation by regulating HIF-1\u03b1\/SPHK2\/S1P axis in ITP","volume":"142","author":"Huang","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.12.028_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111810","article-title":"HIF-1\u03b1 induced by hypoxic condition regulates Treg\/Th17 axis polarization in chronic immune thrombocytopenia","volume":"131","author":"Gu","year":"2024","journal-title":"Int Immunopharmacol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624007773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624007773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T02:29:57Z","timestamp":1775010597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624007773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1538783624007773"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.12.028","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of roxadustat in immune thrombocytopenia: a Mendelian randomization analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.12.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}